Strategic Education (STRA) Q2 2026 Earnings Call Transcript

Strategic Education reported Q2 2026 revenue of $337.3M (+2.7% constant currency) and adjusted diluted EPS of $1.76 (+16% YoY), alongside a 90 bps constant-currency adjusted operating margin expansion to 16.0%. The Education Technology Services segment grew 15.4% to $42.4M with operating margin expanding 520 bps to 46.2%, while U.S. Higher Education lifted operating income to $32.4M (+56% YoY) on stronger retention (89%, all-time high) and healthcare enrollment reaching 52% of the mix. The company recorded a $13.9M Australia labor-related reserve due to an adverse appeals outcome and flagged slower visa approvals, but reiterated confidence in full-year 200 bps adjusted operating margin expansion and expects revenue per student to be roughly flat. Share repurchases totaled ~$32.8M in the quarter, with $141M remaining on authorization.

Analysis

The investable shift is that STRA is becoming less of a pure enrollment story and more of a high-margin employer-benefits education platform. That changes the multiple: recurring corporate relationships and healthcare-skills demand should deserve a higher quality-adjusted valuation than a consumer-search-dependent online school, especially if AI-driven discovery weakens paid acquisition across the sector.

The near-term overhang is Australia, but the market should treat it as a timing/risk-management item rather than a full business reset. The real catalyst path is the September/October High Court decision plus visa processing normalization; if either disappoints, the back-half revenue rebound narrative gets pushed out and the stock can de-rate on duration, not earnings.

Contrarian angle: consensus may be underweight the durability of free cash flow and buybacks, and overweight the one-time legal reserve. The bigger risk is actually that margin expansion looks easier than it is if scholarship savings normalize and revenue-per-student reverts, so a clean beat only persists if employer-affiliated and healthcare enrollment keep compounding faster than the legacy base decays.

Key Decisions for Investors

• Long STRA on any post-print weakness; 3-6 month horizon. Best setup is if the market focuses on the Australia reserve and ignores the employer/healthcare mix shift. Falsify if U.S. higher-ed operating margin stops expanding or revenue-per-student falls below management's roughly flat full-year view.
• Pair trade: long STRA / short LOPE for a 1-3 month relative-value expression. STRA has the better structural mix into employer health-care training and higher incremental margin from ETS; LOPE is more exposed to a slower organic demand environment. Cut the pair if STRA's employer enrollment stalls or LOPE's growth re-accelerates on a channel advantage.
• Watch-list rather than trade: reduce STRA exposure if the Australian High Court declines the appeal and management signals incremental instructional costs are not fully offset by the model changes. That is the main event risk for the next 6-12 weeks.
• No chase on SOPH-style academic-integrity headlines: wait for evidence that integrity controls are hurting conversion or retention before assuming growth impairment. If subscriber growth stays strong while controls tighten, the multiple can expand rather than compress.